Auxly Cannabis Group Inc. (XLY.TO)
CAD 0.09
(0.0%)
CAD 0.09
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 261.9 Million CAD | -21.07% |
| 2022 | 331.82 Million CAD | -26.33% |
| 2021 | 450.42 Million CAD | 18.86% |
| 2020 | 378.96 Million CAD | -7.93% |
| 2019 | 411.59 Million CAD | -10.68% |
| 2018 | 460.81 Million CAD | 397.76% |
| 2017 | 92.57 Million CAD | 22103.88% |
| 2016 | 416.94 Thousand CAD | -42.23% |
| 2015 | 721.73 Thousand CAD | 17.92% |
| 2014 | 612.05 Thousand CAD | 1.31% |
| 2013 | 604.14 Thousand CAD | 10.28% |
| 2012 | 547.84 Thousand CAD | 20.08% |
| 2011 | 456.23 Thousand CAD | 20.01% |
| 2010 | 380.16 Thousand CAD | 39.59% |
| 2009 | 272.34 Thousand CAD | 72.15% |
| 2008 | 158.2 Thousand CAD | 31.48% |
| 2007 | 120.32 Thousand CAD | -99.88% |
| 2006 | 99.43 Million CAD | -6.75% |
| 2005 | 106.63 Million CAD | 42.08% |
| 2004 | 75.05 Million CAD | 88.71% |
| 2003 | 39.77 Million CAD | 13.42% |
| 2002 | 35.06 Million CAD | -12.14% |
| 2001 | 39.91 Million CAD | -5.89% |
| 2000 | 42.41 Million CAD | -9.17% |
| 1999 | 46.69 Million CAD | 81.38% |
| 1998 | 25.74 Million CAD | 29.63% |
| 1997 | 19.85 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 260.61 Million CAD | 0.19% |
| 2024 Q1 | 260.12 Million CAD | -0.68% |
| 2023 Q3 | 304.92 Million CAD | -3.78% |
| 2023 FY | 261.9 Million CAD | -21.07% |
| 2023 Q2 | 316.89 Million CAD | -4.73% |
| 2023 Q4 | 261.9 Million CAD | -14.11% |
| 2023 Q1 | 332.61 Million CAD | 0.24% |
| 2022 Q3 | 345.06 Million CAD | -15.83% |
| 2022 Q4 | 331.82 Million CAD | -3.84% |
| 2022 FY | 331.82 Million CAD | -26.33% |
| 2022 Q2 | 409.96 Million CAD | -1.8% |
| 2022 Q1 | 417.46 Million CAD | -7.32% |
| 2021 Q1 | 389.25 Million CAD | 2.72% |
| 2021 FY | 450.42 Million CAD | 18.86% |
| 2021 Q4 | 450.42 Million CAD | 14.49% |
| 2021 Q3 | 393.42 Million CAD | -1.52% |
| 2021 Q2 | 399.51 Million CAD | 2.63% |
| 2020 Q1 | 390.28 Million CAD | -5.18% |
| 2020 Q4 | 378.96 Million CAD | -0.69% |
| 2020 Q2 | 378.48 Million CAD | -3.02% |
| 2020 Q3 | 381.59 Million CAD | 0.82% |
| 2020 FY | 378.96 Million CAD | -7.93% |
| 2019 FY | 411.59 Million CAD | -10.68% |
| 2019 Q2 | 439.88 Million CAD | -3.51% |
| 2019 Q3 | 568.09 Million CAD | 29.14% |
| 2019 Q1 | 455.9 Million CAD | -1.07% |
| 2019 Q4 | 411.59 Million CAD | -27.55% |
| 2018 Q1 | 281.21 Million CAD | 203.76% |
| 2018 Q3 | 501.04 Million CAD | 4.63% |
| 2018 FY | 460.81 Million CAD | 397.76% |
| 2018 Q4 | 460.81 Million CAD | -8.03% |
| 2018 Q2 | 478.86 Million CAD | 70.29% |
| 2017 Q4 | 92.57 Million CAD | 109.59% |
| 2017 FY | 92.57 Million CAD | 22103.88% |
| 2017 Q3 | 44.17 Million CAD | -8.45% |
| 2017 Q2 | 48.24 Million CAD | 1820.43% |
| 2017 Q1 | 2.51 Million CAD | 502.58% |
| 2016 Q2 | 719.07 Thousand CAD | 1.0% |
| 2016 Q1 | 711.99 Thousand CAD | -1.35% |
| 2016 Q4 | 416.94 Thousand CAD | -44.23% |
| 2016 FY | 416.94 Thousand CAD | -42.23% |
| 2016 Q3 | 747.66 Thousand CAD | 3.98% |
| 2015 Q3 | 636.38 Thousand CAD | 1.2% |
| 2015 Q1 | 622.82 Thousand CAD | 1.76% |
| 2015 FY | 721.73 Thousand CAD | 17.92% |
| 2015 Q2 | 628.84 Thousand CAD | 0.97% |
| 2015 Q4 | 721.73 Thousand CAD | 13.41% |
| 2014 FY | 612.05 Thousand CAD | 1.31% |
| 2014 Q4 | 612.05 Thousand CAD | 1.72% |
| 2014 Q2 | 578.32 Thousand CAD | -3.02% |
| 2014 Q3 | 601.67 Thousand CAD | 4.04% |
| 2014 Q1 | 596.32 Thousand CAD | -1.29% |
| 2013 Q4 | 604.14 Thousand CAD | 1.81% |
| 2013 FY | 604.14 Thousand CAD | 10.28% |
| 2013 Q3 | 593.42 Thousand CAD | 7.43% |
| 2013 Q2 | 552.35 Thousand CAD | -0.61% |
| 2013 Q1 | 555.77 Thousand CAD | 1.45% |
| 2012 Q4 | 547.84 Thousand CAD | 10.14% |
| 2012 Q1 | 487.29 Thousand CAD | 6.81% |
| 2012 Q2 | 471.9 Thousand CAD | -3.16% |
| 2012 FY | 547.84 Thousand CAD | 20.08% |
| 2012 Q3 | 497.39 Thousand CAD | 5.4% |
| 2011 Q2 | 519.09 Thousand CAD | 2.12% |
| 2011 Q3 | 539.85 Thousand CAD | 4.0% |
| 2011 Q4 | 456.23 Thousand CAD | -15.49% |
| 2011 FY | 456.23 Thousand CAD | 20.01% |
| 2011 Q1 | 508.32 Thousand CAD | 33.71% |
| 2010 Q1 | 276.28 Thousand CAD | 1.45% |
| 2010 Q2 | 300.85 Thousand CAD | 8.89% |
| 2010 Q3 | 339.46 Thousand CAD | 12.83% |
| 2010 Q4 | 380.16 Thousand CAD | 11.99% |
| 2010 FY | 380.16 Thousand CAD | 39.59% |
| 2009 FY | 272.34 Thousand CAD | 72.15% |
| 2009 Q2 | 180.06 Thousand CAD | -2.25% |
| 2009 Q1 | 184.21 Thousand CAD | 16.44% |
| 2009 Q4 | 272.34 Thousand CAD | 20.22% |
| 2009 Q3 | 226.53 Thousand CAD | 25.8% |
| 2008 FY | 158.2 Thousand CAD | 31.48% |
| 2008 Q1 | 261.03 Thousand CAD | 116.95% |
| 2008 Q2 | 231.32 Thousand CAD | -11.38% |
| 2008 Q3 | 279.48 Thousand CAD | 20.82% |
| 2008 Q4 | 158.2 Thousand CAD | -43.39% |
| 2007 Q2 | 91.69 Million CAD | -7.77% |
| 2007 Q1 | 99.42 Million CAD | -0.01% |
| 2007 Q4 | 120.32 Thousand CAD | -99.83% |
| 2007 Q3 | 70.01 Million CAD | -23.65% |
| 2007 FY | 120.32 Thousand CAD | -99.88% |
| 2006 Q3 | 98.16 Million CAD | -12.17% |
| 2006 Q4 | 99.43 Million CAD | 1.3% |
| 2006 Q2 | 111.76 Million CAD | 2.07% |
| 2006 Q1 | 109.49 Million CAD | 2.68% |
| 2006 FY | 99.43 Million CAD | -6.75% |
| 2005 Q3 | 83.54 Million CAD | 0.29% |
| 2005 Q1 | 79.95 Million CAD | 6.53% |
| 2005 Q4 | 106.63 Million CAD | 27.64% |
| 2005 FY | 106.63 Million CAD | 42.08% |
| 2005 Q2 | 83.29 Million CAD | 4.18% |
| 2004 Q2 | 53.41 Million CAD | 18.98% |
| 2004 Q3 | 55.96 Million CAD | 4.78% |
| 2004 Q4 | 75.05 Million CAD | 34.11% |
| 2004 FY | 75.05 Million CAD | 88.71% |
| 2004 Q1 | 44.89 Million CAD | 12.87% |
| 2003 FY | 39.77 Million CAD | 13.42% |
| 2003 Q4 | 39.77 Million CAD | 12.34% |
| 2003 Q2 | 34.9 Million CAD | -0.62% |
| 2003 Q3 | 35.4 Million CAD | 1.43% |
| 2003 Q1 | 35.12 Million CAD | 0.16% |
| 2002 Q2 | 40.05 Million CAD | 2.32% |
| 2002 FY | 35.06 Million CAD | -12.14% |
| 2002 Q4 | 35.06 Million CAD | -12.63% |
| 2002 Q3 | 40.13 Million CAD | 0.21% |
| 2002 Q1 | 39.14 Million CAD | -1.92% |
| 2001 Q2 | 39.75 Million CAD | -5.74% |
| 2001 Q1 | 42.18 Million CAD | -0.54% |
| 2001 Q3 | 40.37 Million CAD | 1.56% |
| 2001 FY | 39.91 Million CAD | -5.89% |
| 2001 Q4 | 39.91 Million CAD | -1.15% |
| 2000 Q3 | 46.18 Million CAD | -2.57% |
| 2000 FY | 42.41 Million CAD | -9.17% |
| 2000 Q1 | 46.99 Million CAD | 0.65% |
| 2000 Q4 | 42.41 Million CAD | -8.18% |
| 2000 Q2 | 47.4 Million CAD | 0.88% |
| 1999 Q3 | 44.45 Million CAD | 57.97% |
| 1999 Q2 | 28.14 Million CAD | -0.81% |
| 1999 Q4 | 46.69 Million CAD | 5.02% |
| 1999 FY | 46.69 Million CAD | 81.38% |
| 1999 Q1 | 28.37 Million CAD | 0.0% |
| 1998 FY | 25.74 Million CAD | 29.63% |
| 1998 Q2 | 25.64 Million CAD | -1.03% |
| 1998 Q1 | 25.91 Million CAD | 25.72% |
| 1997 Q4 | 20.6 Million CAD | 0.0% |
| 1997 FY | 19.85 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 68.772% |
| Avicanna Inc. | 21.97 Million CAD | -1092.038% |
| Avant Brands Inc. | 82.55 Million CAD | -217.259% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -613.625% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -964.737% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 72.3% |
| MediPharm Labs Corp. | 63.93 Million CAD | -309.628% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 12.247% |
| Canopy Growth Corporation | 1.3 Billion CAD | 79.859% |
| Willow Biosciences Inc. | 6.67 Million CAD | -3824.831% |